Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid

Toxicology and Applied Pharmacology

Volumn 227, Issue 1, 2008, Pages 76-83

  Suzuki, Kazuo T ^a   Tsuji, Yoshiro ^a   Ohta, Yuki ^a   Suzuki, Noriyuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Methylseleninic acid; Methylselenol; Se methylselenocysteine; Selenite; Selenium; Speciation; Stable isotope

Indexed keywords

CYSTEINE DERIVATIVE; METHYLSELENINIC ACID; SE METHYLSELENOCYSTEINE; SELENITE; SELENIUM; SELENIUM DERIVATIVE; STABLE ISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CHEMICAL REACTION; CONTROLLED STUDY; ISOTOPE LABELING; KIDNEY; LIVER; MALE; METHYLATION; NONHUMAN; ORGAN DISTRIBUTION; RAT; REDUCTION; SPLEEN;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; MALE; MASS SPECTROMETRY; ORGANOSELENIUM COMPOUNDS; RATS; REFERENCE STANDARDS; TISSUE DISTRIBUTION;

RATTUS;

EID: 38749099484     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.10.001     Document Type: Article

References (38)

1. Andreadou I., Menge W.M., Commandeur J.N., Worthington E.A., and Vermeulen N.P. Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of beta-elimination reactions in rat renal cytosol. J. Med. Chem. 39 (1996) 2040-2046
2. Arnault I., and Auger J. Seleno-compounds in garlic and onion. J. Chromatogr. A 1112 (2006) 23-30
3. Birringer M., Pilawa S., and Flohe L. Trends in selenium biochemistry. Nat. Prod. Rep. 19 (2002) 693-718
4. Cho S.D., Jiang C., Malewicz B., Dong Y., Young C.Y., Kang K.S., Lee Y.S., Ip C., and Lu J. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol. Cancer Ther. 3 (2004) 605-611
5. Combs G.F., and Gray W.P. Chemopreventive agents: selenium. Pharmacol. Ther. 79 (1998) 179-192
6. Davis R.L., and Spallholz J.E. Inhibition of selenite-catalyzed superoxide generation and formation of elemental selenium (Se(0)) by copper, zinc, and aurintricarboxylic acid (ATA). Biochem. Pharmacol. 51 (1996) 1015-1020
7. Dong Y., Lisk D., Block E., and Ip C. Characterization of the biological activity of glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic. Cancer Res. 61 (2001) 2923-2928
8. Dumont E., Ogra Y., Vanhaecke F., Suzuki K.T., and Cornelis R. Liquid chromatography-mass spectrometry (LC-MS): a powerful combination for selenium speciation in garlic (Allium sativum). Anal. Bioanal. Chem. 384 (2006) 1196-1206
9. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475 (2001) 123-139
10. Fleming J., Ghose A., and Harrison P.R. Molecular mechanisms of cancer prevention by selenium compounds. Nutr. Cancer 40 (2001) 42-49
11. Francesconi K.A., and Pannier F. Selenium metabolites in urine: a critical overview of past work and current status. Clin. Chem. 50 (2004) 2240-2253
12. Haratake M., Fujimoto K., Ono M., and Nakayama M. Selenium binding to human hemoglobin via selenotrisulfide. Biochim. Biophys. Acta 1723 (2005) 215-220
13. Hatfield D.L., and Gladyshev V.N. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22 (2002) 3565-3576
14. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 128 (1998) 1845-1854
15. Ip C., Birringer M., Block E., Kotrebai M., Tyson J.F., Uden P.C., and Lisk D.J. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J. Agric. Food Chem. 48 (2000) 2062-2070
16. Ip C., Thompson H.J., Zhu Z., and Ganther H.E. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60 (2000) 2882-2886
17. Kobayashi Y., Ogra Y., Ishiwata K., Takayama H., Aimi N., and Suzuki K.T. Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15932-15936
18. Lee S.O., Yeon Chun J., Nadiminty N., Trump D.L., Ip C., Dong Y., and Gao A.C. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 66 (2006) 1070-1075
19. Ogra Y., Hatano T., Ohmichi M., and Suzuki K.T. Oxidative production of monomethylated selenium from the major urinary selenometabolite, selenosugar. J. Anal. At. Spectrom. 18 (2003) 1252-1255
20. Ogra Y., Ishiwata K., and Suzuki K.T. Effects of deuterium in octopole reaction and collision cell ICP-MS on detection of selenium in extracellular fluids. Anal. Chim. Acta 554 (2005) 123-129
21. Ohta, Y., Suzuki, K.T., in press. Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium. Toxicol. Appl. Pharmacol. (TAAP-D-07-519).
22. Okuno T., Kubota T., Kuroda T., Ueno H., and Nakamuro K. Contribution of enzymic alpha,gamma-elimination reaction in detoxification pathway of selenomethionine in mouse liver. Toxicol. Appl. Pharmacol. 176 (2001) 18-23
23. Okuno T., Motobayashi S., Ueno H., and Nakamuro K. Purification and characterization of mouse hepatic enzyme that converts selenomethionine to methylselenol by its alpha,gamma-elimination. Biol. Trace Elem. Res. 106 (2005) 77-94
24. Schrauzer G.N. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J. Nutr. 130 (2000) 1653-1656
25. Schrauzer G.N. Anticarcinogenic effects of selenium. Cell. Mol. Life Sci. 57 (2000) 1864-1874
26. III) by red blood cells. Chem. Res. Toxicol. 14 (2001) 1446-1452
27. Suzuki K.T. Metabolomics of selenium: Se metabolites based on speciation studies. J. Health Sci. 52 (2005) 107-114
28. Suzuki K.T., and Itoh M. Metabolism of selenite labelled with enriched stable isotope in the bloodstream. J. Chromatogr., B, Biomed. Sci. Appl. 692 (1997) 15-22
29. Suzuki K.T., Kurasaki K., Okazaki N., and Ogra Y. Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes. Toxicol. Appl. Pharmacol. 206 (2005) 1-8
30. 82Se-selenite. Toxicol. Appl. Pharmacol. 217 (2006) 185-195
31. Suzuki K.T., Kurasaki K., Ogawa S., and Suzuki N. Metabolic transformation of methylseleninic acid through key selenium intermediate selenide. Toxicol. Appl. Pharmacol. 215 (2006) 189-197
32. 77Se-methylseleninic acid compared simultaneously with those of three related selenocompounds. Toxicol. Appl. Pharmacol. 217 (2006) 51-62
33. 77Se-selenomethionine by absolute labeling and speciation. Toxicol. Appl. Pharmacol. 217 (2006) 43-50
34. Suzuki K.T., Kurasaki K., and Suzuki N. Selenocysteine β-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide. Biochim. Biophys. Acta 1770 (2007) 1053-1061
35. Veres Z., Kim I.Y., Scholz T.D., and Stadtman T.C. Selenophosphate synthetase. Enzyme properties and catalytic reaction. J. Biol. Chem. 269 (1994) 10597-10603
36. Wang Z., Jiang C., Ganther H., and Lu J. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res. 61 (2001) 7171-7178
37. Whanger P.D., Ip C., Polan C.E., Uden P.C., and Welbaum G. Tumorigesis, metabolism, speciation, bioavailability and tissue deposition of selenium in selenium-enriched ramps (Allium tricoccum). J. Agric. Food Chem. 48 (2000) 5723-5730
38. Yamanoshita O., Ichihara S., Hama H., Ichihara G., Chiba M., Kamijima M., Takeda I., and Nakajima T. Chemopreventive effect of selenium-enriched Japanese radish sprout against breast cancer induced by 7,12-dimethylbenz[a]anthracene in rats. Tohoku J. Exp. Med. 212 (2007) 191-198